Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to -$1.6 million.

  • Lemaitre Vascular's Net Cash Flow rose 753.11% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 7348.07%. This contributed to the annual value of $2.1 million for FY2024, which is 5706.42% down from last year.
  • According to the latest figures from Q3 2025, Lemaitre Vascular's Net Cash Flow is -$1.6 million, which was up 753.11% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's Net Cash Flow ranged from a high of $5.8 million in Q4 2023 and a low of -$4.2 million during Q2 2024
  • In the last 5 years, Lemaitre Vascular's Net Cash Flow had a median value of -$1.2 million in 2023 and averaged -$24368.4.
  • In the last 5 years, Lemaitre Vascular's Net Cash Flow crashed by 41143.85% in 2021 and then skyrocketed by 37837.57% in 2022.
  • Lemaitre Vascular's Net Cash Flow (Quarter) stood at -$3.3 million in 2021, then skyrocketed by 146.37% to $1.6 million in 2022, then skyrocketed by 273.41% to $5.8 million in 2023, then dropped by 7.38% to $5.4 million in 2024, then crashed by 130.4% to -$1.6 million in 2025.
  • Its Net Cash Flow was -$1.6 million in Q3 2025, compared to $1.2 million in Q2 2025 and -$520000.0 in Q1 2025.